Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Ratios

Glucotrack (GCTK) Net Income towards Common Stockholders (2016 - 2020)

Glucotrack's Net Income towards Common Stockholders history spans 7 years, with the latest figure at -$878000.0 for Q4 2020.

  • For the quarter ending Q4 2020, Net Income towards Common Stockholders fell 113.71% year-over-year to -$878000.0, compared with a TTM value of -$3.1 million through Dec 2020, down 188.9%, and an annual FY2025 reading of -$16.1 million, down 10.61% over the prior year.
  • Net Income towards Common Stockholders for Q4 2020 was -$878000.0 at Glucotrack, up from -$887000.0 in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $18.5 million in Q4 2017, with the low at -$2.7 million in Q2 2017.
  • Average Net Income towards Common Stockholders over 5 years is $376542.3, with a median of -$995951.0 recorded in 2018.
  • Year-over-year, Net Income towards Common Stockholders skyrocketed 1497.61% in 2017 and then crashed 155.23% in 2019.
  • Tracing GCTK's Net Income towards Common Stockholders over 5 years: stood at -$1.3 million in 2016, then skyrocketed by 1497.61% to $18.5 million in 2017, then plummeted by 105.48% to -$1.0 million in 2018, then soared by 733.34% to $6.4 million in 2019, then plummeted by 113.71% to -$878000.0 in 2020.
  • Per Business Quant, the three most recent readings for GCTK's Net Income towards Common Stockholders are -$878000.0 (Q4 2020), -$887000.0 (Q3 2020), and -$611000.0 (Q2 2020).